Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,409
Closed -$242K 372
2022
Q3
$242K Buy
3,409
+23
+0.7% +$1.81K 0.02% 291
2022
Q2
$248K Buy
3,386
+1
+0% +$81 0.02% 292
2022
Q1
$306K Buy
+3,385
New +$319K 0.02% 304
2015
Q3
Sell
-671,770
Closed -$34.5M 300
2015
Q2
$34.5M Sell
671,770
-310,515
-32% -$15.1M 0.39% 75
2015
Q1
$44.3M Sell
982,285
-197,166
-17% -$8.8M 0.48% 58
2014
Q4
$55.2M Sell
1,179,451
-461,921
-28% -$21.7M 0.58% 56
2014
Q3
$81.8M Sell
1,641,372
-415,693
-20% -$20.8M 0.79% 40
2014
Q2
$103M Sell
2,057,065
-81,281
-4% -$3.97M 0.96% 32
2014
Q1
$111M Sell
2,138,346
-251,881
-11% -$12.1M 1.14% 27
2013
Q4
$114M Buy
2,390,227
+54,235
+2% +$2.38M 1.17% 24
2013
Q3
$91.8M Sell
2,335,992
-78,858
-3% -$3.28M 0.99% 30
2013
Q2
$96.2M Buy
+2,414,850
New +$90.2M 1.09% 23

Other funds holding CMA

Advisory Research's CMA Position: Q4 2022 in Review

Advisory Research sold out of Comerica (CMA) in Q4 2022, closing a stake of 3,409 shares — an estimated $242K sold.

Advisory Research first reported a position in CMA in Q2 2013 and held it in 12 quarters. The position peaked at $114M in Q4 2013. 568 funds tracked by Wall St. Rank hold CMA as of Q4 2022.

  • Advisory Research reported no remaining Comerica position as of Q4 2022 after selling out during the quarter.
  • Advisory Research sold 3,409 Comerica shares in Q4 2022, an estimated $242K.
  • Advisory Research first reported a position in Comerica in Q2 2013 and held it in 12 quarters.
  • Advisory Research's Comerica position peaked at $114M in Q4 2013.
  • 568 funds tracked by Wall St. Rank held Comerica as of Q4 2022.

Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.